HHLR ADVISORS, LTD.HHLR ADVISORS, LTD.

Institutional investor · Portfolio as of Q4 2022

SEC EDGAR SourceSEC Filings

Top Holdings67 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
ONCONC
ADR

BEIGENE LTD-ADR

5.5M$1.2B25.4%$134.02+64.11%
17 qtrssince 2018-Q4
Unchanged
0
JDJD
ADR

JD.COM INC-ADR

6.6M$371.8M7.8%$52.21+0.02%
17 qtrssince 2018-Q4
Increased
63
BEKEBEKE
ADR

KE HOLDINGS INC-ADR

21M$293.8M6.2%$25.71-48.65%
10 qtrssince 2020-Q3
Increased
94
BABABABA
ADR

ALIBABA GROUP HOLDING-SP ADR

3.1M$275.1M5.8%$98.77-15.30%
3 qtrssince 2022-Q2
Increased
79
VIPSVIPS
ADR

VIPSHOP HLDGS LTD

19M$259M5.5%$12.57+1.95%
8 qtrssince 2021-Q1
Decreased
0
LEGNLEGN
ADR

Legend Biotech Corp. Sponsored ADR

5.1M$256.4M5.4%$46.09+8.30%
11 qtrssince 2020-Q2
Unchanged
0

FREEPORT-MCMORAN INC

6.3M$238.4M5.0%$36.330.00%
1 qtr
New
95
PDDPDD
ADR

PDD HOLDINGS INC

2.9M$236.8M5.0%$68.26+19.47%
3 qtrssince 2022-Q2
Increased
76

SALESFORCE.COM INC

1.7M$229.5M4.8%$206.97-36.70%
12 qtrssince 2020-Q1
Decreased
0

DOORDASH INC - A

4.5M$219.9M4.6%$116.24-58.00%
9 qtrssince 2020-Q4
Decreased
0

ON HLDG AG

5.5M$93.8M2.0%$30.90-44.47%
6 qtrssince 2021-Q3
Unchanged
0

CYTEK BIOSCIENCES INC

8.7M$88.7M1.9%$20.96-51.29%
6 qtrssince 2021-Q3
Decreased
0
DQDQ
ADR

DAQO NEW ENERGY CORP

2.1M$81.1M1.7%$64.26-39.91%
4 qtrssince 2022-Q1
Unchanged
0

MONDELEZ INTERNATIONAL INC-A

1.1M$71.4M1.5%$33.70+82.46%
17 qtrssince 2018-Q4
Decreased
0
IQIQ
ADR

IQIYI INC

12.2M$64.5M1.4%$18.39-71.18%
17 qtrssince 2018-Q4
Decreased
0
YSYSG
ADR

Yatsen Holding Limited

34.9M$51M1.1%

COUPANG INC

3.4M$49.7M1.0%$25.60-42.55%
6 qtrssince 2021-Q3
Unchanged
0
ENFNENFNDelisted

ENFUSION INC

5M$48.1M1.0%
5 qtrssince 2021-Q4
Unchanged
0

MICROSOFT CORP

174,100$41.8M0.9%$236.67-1.03%
3 qtrssince 2022-Q2
Increased
47

BRIDGEBIO PHARMA INC

5.2M$39.5M0.8%$28.25-73.03%
15 qtrssince 2019-Q2
Decreased
0
$4.7B
AUM
67
Positions
Q4 2022
Filing
Rating · 3.5
Quarterly Portfolio Change
-21%Q3'21$7.6B-15%Q4'21$6.5B-26%Q1'22$4.8B-3%Q2'22$4.7B-18%Q3'22$3.8B+25%Q4'22$4.7B
Activity profile
$ moved · Q4'22
New27%Increased31%Decreased38%Exited4%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.0 years
<1Q13%1-4Q10%1-2Y21%2Y+55%

HHLR ADVISORS, LTD. manages $4.7B across 67 positions as of Q4 2022. Top holdings: ONC (25.4%), JD (7.8%), BEKE (6.2%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3.5/5.0.

Q4 2022 Summary

Active quarter - 12 new positions, 6 exits, 9 increased. Top move: FCX (NEW, conviction 95). Portfolio: $4.7B across 67 positions.

Top holdings by portfolio weight

Total AUM$5B
ONC25.41%
JD7.85%
BEKE6.20%
BABA5.81%
VIPS5.47%
LEGN5.41%
FCX5.03%
PDD5.00%
CRM4.85%
DASH4.64%
Other1.98%

Portfolio allocation by GICS sector

Sectors9
Healthcare35.80%
Consumer Cyclical33.23%
Technology11.09%
Real Estate6.22%
Basic Materials5.04%
Communication Services3.11%
Unknown2.63%
Consumer Defensive2.59%
Financial Services0.29%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Consumer Cyclical, Technology
Compare DNA across all funds
7-dimension quality assessment
Strong(3.5 / 5.0)
Track RecordNo data
Conviction42
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used